us are unprecedented These just for times, today. Thanks, joining Amy, all thank and Amy noted. you as
which a pandemic, most of the is profound us. are We particularly midst public global the effects having in vulnerable among on health,
world-class disease COVID-XX. own novel fights masks, life, helping this Goal coronavirus system here ResMed ResMed with simple. of is X against and one the goals top our breathe ventilation immune preservation causes, the while ventilators and time, it at this During their people are
help market-leading world-leading and ResMedians, two solutions can't treat XXX the services delivery our of sleep goal apnea, the in worldwide, providing X,XXX skilled software amazing million health care prefer homes, nursing of disease products well pulmonary place providers, chronic people, and asthma the people because we care their XXX to as delivered breathe in three and take with our is medical anyone home. be, better. ongoing to ongoing production importantly, by obstructive without equipment Goal where home countries of facilities, team nursing of of And is safety and hospice, over as the to people
drive to call of clinicians, procedures as are masks I've these in myself of ResMed engaged and of are who tubing feats My I own safety more providers, deliver frontline a clinicians stories patients, all showing as respiratory solutions today. than They of components and is impressive crisis. worldwide. to source to as software the ventilators systems from around using our am never daily and life-changing proud support including Every ventilator our such the global inbox and world, health updated well ResMedian up been workers, ResMedians, demonstrating team to is and day, and COVID-XX every produce therapists heroes, our with beyond. one compassion ingenuity, fully overflowing e-mail and
but is in outbreak many thousands the for up every a from XX team, ResMed Hubei He China our Hubei of or know a saved from of Wuhan, first the example one story ventilators don't weeks suit We day actually setting good that produced donned just who share To the hazmat that full ventilator there there guardian province, corona was teammate. region. of a in hero in in people call ventilator ResMed the calling on many lives have ResMed including province, GA angel we fortune my right and in the this ResMed of I masks, how gentleman China. him,
of up to this those that crisis inspired how beyond. the start I'm and I by April the through January you patients all you and So and in ResMed duration thank you there and stepped for to at heroes, now say help
As company region. and over resources our XXX in this to have to efforts countries, address moves mobilized we providing deadly solutions disease region a from global COVID-XX as
accelerated ventilators, patients distribution including noninvasive no of production as live. well for masks where them as ventilators, need ventilation devices and who have matter they bilevel invasive the most, We
including from produced that XXXX, invasive XX,XXX bilevels our a the quarter. expectations up quarter We on over noninvasive ventilators in we the publicly. increase ventilators, during living and same is to threefold production This set the
more our ventilation We tenfold. driven tenfold a have also actually than mask in increase production,
We of global COVID-XX key is models using world. the ethical of these of our needs patients our life. epidemiology-based on of surge around worldwide the principle distribution are preservation a ventilation of And based the aligning model products ventilation guiding
and can just starting to the begin systems months quarters over care patient countries to continues across to Europe coming America future more and as We and support and and South North surges East beyond. health will COVID-XX Africa, Asia, weeks, with Middle days, America, impact do in
and while safety earlier, health, of ResMed ensuring list. always at we priority outcomes people, said our top these our achieve I place to as can do able nothing. team been that have wellbeing of the Without we our We the
all Our function have whose actions included for that. work-from-home job allows policies for
technical instituted of have mask service for teams wearing policies protocols screening, noncontact and distancing all our supply temperature production, distribution worldwide. chain, We physical and
now our just such home. tech be from While as global these we of can't jobs service working from home, done have and production, around distribution XX% important team
we're world-class plants, plan do as that. countries established get back and manufacturing centers work and quality and offices, have to distribution procedures in all to cities safety ready our and to We of
are these with and services customers us Safety quality ResMed our supply times. beyond. and at DNA our and support to sustainable COVID-XX of crisis than ever, this throughout products, enable a at all solutions more here of part And capabilities today,
sacrifice and personal to at changing individual for and care with gratitude to care worldwide. into well the especially clinicians pathways patients Respiratory invasive workers on triaging others full with beyond therapists, this noninvasive also These care extraordinary need intubation in with time. the efforts and I as of for health this many critical of critical extraordinary from advanced express each appreciation want coronavirus novel endotracheal people frontline to the therapy, that. bilevel my symptoms of therapy people who the to demonstrated nurses, ResMed, are the ventilation depending doctors CPAP boundary have leadership acuity various therapeutic ventilation as hospitals more
clinicians includes using are full ResMed that ventilators These with clinician. which and masks risk ventilation person-to-person ResMed engagement, still direct for protective even equipment with personal significant
person-to-person to telehealth of management. digital with working ventilation to Examples solutions try minimize patient interaction. are include worldwide to remote population this unneeded monitoring We devices, of drive virtual customers and pathways
and devices to connectivity XX million available including our have over We with myAir cloud-based solutions, AirView.
X nights of million XX X as in billion medical the data as over billion over nights, well patients have respiratory We cloud.
a digital field We in running COVID-XX start of this well before had crisis. the health
benefits respiratory and positive awful has to more physicians. health therapists, and this that the One nurses outcomes out of more health brought Digital of efficiency and crisis better the respiratory brings importance forefront safety the for it patients. cost for the is critical health of scalability, of few also digital of care benefits
is believe, this as digital Throughout have and on world's today, changes by continue ResMed building end-to-end despite the our and best outside today. including even for as the well hospital. sleep and software execute pathways the wins we asthma all for COPD to that's XXXX more care we competes quarter, strategy, crisis where apnea, the for brought Fundamentally, ResMed believe this out-of-hospital the through health expanding continued long-term health, coronavirus, health ResMed where that future so, network. That's care of to
the efficiency, The point. better efficacy, pathways the and of health the the has The establish for and at health nurses scale scale, noncontact the the COVID-XX proved digital quality physicians and the an care patients. pandemic interesting of can more we therapists, better
care improve have our million XXX lives by We XXXX. accelerated ability over outside-the-hospital in to health
to ResMed across we in see even and kinetics of and continues as on fundamentals strong, to The it to America America, business from uncertainty COVID-XX and the regions geographies, the Europe, worldwide. to move our North is South changing now Africa disease as dynamics Asia of
our We our as increased our in of Astral, Lumis from ventilators, GA. such Stellar, and are AirCurve, as as Flexo well seeing noninvasive ventilators the tailwinds demand business
ventilation for are solutions. mask We increased seeing also demand
the flattens, from COVID-XX exactly each learning moves. for as hospital, for patient demand not are and how will at surges, And of flow do COVID-XX modeling there. know demand are we global each we for surge virus and each We country But each this pretty long as that city, for using flow each we last good curves getting and the our patient city these then epidemiology peaks serve. model region of
at as as source to production year's is element ability response short-term around multiple product to incredible Currently, ventilator on earlier, our And to worldwide. our I already And COVID-XX we capacity. our our surge and Xx the critical moves last best ship a are ability to its keep is key lot doing also peak are in meet to we production maximum virus this of impact geographies capacity. components at the flow depends ability demand -- in deliver in and the world. A mentioned
want clear on I though. point, this be to
can as face high doing and our keep Even we down. products, increased to costs we that keep we demand everything efficiency are to for our
are to humanitarian primary is to ResMed, we goal preserve At ventilators Our to XXX% life. in locked. committed patients order COVID-XX for enabling access
we and pricing per keeping in response COVID-XX. our not unit prices profit are will We increase opportunistically steady, or to
years innovation particularly will will technology through quarters, at health there innovation. in research in the fields software digital that ability as believe that development drive our pipeline, the crisis to lessons coming enhance during and learned here We product coming as and be our ResMed our the well of
today, will more competitively in positioned are We very these tomorrow. we so think be we even but fields
have our business. balancing we well While also in to health executing response core public crisis, been global the our
geographies, contributions software-as-a-service our We sleep details our in few quarter. have businesses provide the along few solid for XXXX Brett a highlights from third will our Sandercock, provide asthma minutes, execution for In COPD XXXX. outlook discuss I'll quarter the of across towards during delivered ResMed just first, our remainder business along our strong fiscal CFO, and with the a apnea, milestones growth briefly performance, quarter. some with and But strategy financial of the our financial with
third positive is revenue, up of across product momentum just global we software fiscal growth in XXXX, year markets. XX% So million quarter for $XXX portfolio, and delivered our solutions and the reflecting quarterly year-over-year, around which
impact mentioned global demand be quarter. the and million ventilators, incremental noninvasive devices, As for ventilators bilevel $XX tailwinds to of We I approximately for including as estimate accessories, increased part of the COVID-XX-related have invasive and masks our the during revenue response, we seen earlier. COVID-XX
a in cash this dividends Board as during the cash quarterly declared revenue, from million in us to return to $XXX enabling our $XXX operations quarter, from today. we So million by generated flow strong shareholders,
crisis continue the COVID-XX the ventilators to the resources to quarter. and enterprise with our research research and people the future in asthma clinical inventors going core work investments apnea, in invest development masks our includes and This help innovation people during ventilation to well for and of help as shifting sleep increases investment businesses. double-digit physicians, We growth as during our R&D keeping technical software-as-a-service clinicians, worldwide COPD, and ongoing and
path clear away digital a enabling suffering from those set care the for asthma ResMed people from is have health lives healthier way as the apnea, and our to in for We in the technology, as transforming sleep live leader COPD a well portfolio position maintain settings delivered health global hospital. to as of
third, of better life our customer, chronic costs; products, quality who care against hospital. breathe from long-term of person the triple to of help the slowing and aim ultimate quality progress higher our execution for our sleep second, of: improving away reducing strategy deliver progression; overall disease The our life better, health and them uses first, drives system the
We person other best positions sleep their ResMed mental to quality health from a better, when cardiovascular breathe away better health people we beyond. help in and disease, better chronic care, acute live and those achieve help life disease including conditions, a this outcome that believe of diabetes,
and multiple partnerships to private including forming our Watch space. beyond. long-term Verily venture many with this health these are drive We benefits, joint other partnerships
to priorities differentiate track Number just solutions have outcomes, so to do can our priority. we're health reduce together, network devices three Number the two, technology and delivered and costs enhance focus. and and that on physicians, for priority grow COPD hospital, sleep asthma third That's #X improve health is That's medical our apnea, that our to clinical triple We our across world-leading digital outside deliver well one, patients software aim. build that is experiences. our best that. global providers clear engage and markets. care and core the guide we And daily to to patient world's businesses
strong driving these We growth product an growth advanced this priorities highlights innovation. have have of I'll X on globally. a had geographic exceptionally demonstrate We on areas including and a briefly are during quarter, the all momentum and few touch quarter where and we to XX% basis, recent on
and growth, United combined including distributed XX% regions increase Our States, currency strong combined as increase as across strong regions. in an the of other America and Asia delivered well constant Canada a XX% incredibly and team geographic the Europe, Latin
there earlier, the above around of COVID-XX in so underlying remained quarter robust, in quarter. an $XXX the core the discussed of in As was from the revenue, business in over In surge that's around demand of surge X.X% impact $XX ventilation of our for and ongoing the revenues short, of million that million demand.
makes X This choice reduce by data months. billion lives basis, million over the a our complete of a allow ability drive Including supported field leader by outcomes. them we help On XX physicians, during the digital improved health benefit million and solutions mask our for customers, the live in for ResMed and improve to is sophisticated systems. in medical product last to health providing actionable for the in lives care providers these system helping These XXX the over them months, or better respiratory to together of with for global nights number, ResMed a device customers, out-of-hospital partner The efficiency, improve a data these a software health of patients, to this breathe during XX our including data us impacted person digital we over last lives insights increase perform XX cloud. and life. ResMed and costs and analytics better
a our of So apnea core shifting sleep business. discussion to
We are COVID-XX-related in patient sleep. the impact new diagnoses significant from on seeing lockdowns
of pulmonary have declines focus are their often treat physicians rates in critical to city, that clinics increased maintained, business actually quarter. their We hospital. markets. and affected have to region, we sleep the that shifting seen during diagnosis double-digit sleep are many comes care patients note especially the to accessories dimension surge our state, the in work closed. important clinics, mask in hospital not their COVID-XX and Many only It seen And their as their is resupply temporarily clinics but
forward, incredibly and these the device fact diagnostic we apnea upsurge decline people uncertainty to and the activity million revenue revenue are will XXX future over the clear sleep facts, there high, apnea maintain number and sleep know, ramp up and apnea and the world. ventilation there sleep growth its both the somewhat. mask that prevalence crisis extent to we look is mask worldwide. COPD or and revenue of it's will As sleep in home lifted a And many lockdowns what sleep is backlog offset whether not for we ventilation now one, during two, that as clinics know decelerate in the But device testing, preparing physicians around their in remains are
work visits For procedures modeling come care back customer-by-customer, physician tests up will the online have are lockdown sleep primary economy tests. elective and in-laboratory of through on-premise patients opens sleep undiagnosed region, the both again will up through backlog apnea, been built in that scale a the beyond. back or has and with then for Physicians city-by-city testing we COVID-XX country-by-country and through their as portfolio the to how and apnea and telehealth in-lab and therapists those home medical of
normal new on and The behaviors velocity will depend we're what return calling of for pathway diagnostic regulations the care. a local and rate patient
they to scale in-lab backlog can test best time over home to some We modeled apnea meet ensure Europe, test cities starting and their customers of in back the U.S. carefully we we see Asia them and of open as have these scale start experience the support open-ups the demand. their And in to up we're sleep throughout real-time that opening up in and have
connectable million, medical as more apnea we're our in Even today, accelerate working our customers models apnea I are every XXX% remote sleep patient that closely and therapy And there setup ongoing around home the sleep field to well are where pathways cloud distributed remote over earlier, those XX and with pursuing apnea have we monitoring. testing as patient devices the day. customers out world, these mentioned sleep on
partnerships And note and these on as to only to we decades we remote will digital of types telehealth COVID-XX that we've these types in COVID-XX. years for and working monitoring things and increase and believe important health new due been states. These are to a It's of aren't move into models world. due some post-COVID-XX
on return In And to for health physician on and with Solutions setting. as the also health innovation, rolled outpatient interact will patient not by pilot digital need physician We directly care a terms that for chat trend information focus view to so preventative video only patient telehealth reduce and patient. reimbursement the of have AirView, of room combination access out worker. over the methodologies a changes overall the COVID-XX we and the it accelerated but that a we both and recently a and think new or a Air recovered that safety be emergency can in the this health will benefits the can
this can over a across network, like patient lives. when scale Solutions million including digital leveraged provide health XXX incredible
to I increase the quarter in noted and tenfold we put of monies our double As the in ventilation expedite development production by work quarter, in in these R&D capacity to digits ventilator our earlier, investments the grew and research tripling mask and production.
and asthma ventilation CPAP, apnea, our time, though, for therapy sleep to around in including help white continued create clinicians to crisis, with software-as-a-service. help businesses future in have At we and COVID-XX growth the management, with with oxygen, the therapy. solutions COVID-XX partnerships same and practice best practice to formed bilevel clinical the core also share have paper, ventilation invest noninvasive We between world help to in COPD, therapy, triage ventilation clinical invasive
business, the we innovation face full category. most example complete the tube-up the the in all As of This full mask apnea first now FXXi. face This gives CPAP AirFit during a our in sleep competition introduced quarter versus the an mask with our planet. is this on the design core ResMed product portfolio
this to nasal lumber do allows simple of prevents the in freedom the can The night during innovative position. the so quickly also the they sleep The follows ultimate In reattach best any for naturally that movement in patient, tubing, what the FXXi tube-up the to at gives release elbow FXXi making So and night. AirFit very design has to customers? of it its essence, an bridge, does a on it that irritation the of users has back therapy disconnect architecture to start therapy and cushion start quick it mask from stop and that the morning. customer, the
All it improves product the very quality day, freedom is a supports unique for improves of their they their life improves of was their in movement to sleep, patient. it built this the improve the cycle the Clearly, FXXi, and aim, AirFit have this pretty environment. of early up, FXXi third life. don't tenet for If it product and amid the triple global launched technology into the our life that wake
some we've the respiratory of functionality early noise able been as benefit signal, in the patient, the that in the despite customer, ultimate innovation However, physicians, to the of recognize FXXi. the acceptance see and and therapists good
attention. in detect treatment the study the at to COPD. can help patients lung we is quarter, and the function invested through remote high-level Thoracic when daily in recordings physicians or commence improve Additionally, partnership changes American from to to during a how research early The seek to grant. not-for-profit look notify the management The intensive Foundation research the aims and monitoring to of goal of more medical $XXX,XXX study and/or Society with patients with
these systems. worldwide, served and Nearly currently suffer well do global we care people XXX not are believe million health COPD people by from
patients the findings Our forward. the vision health nonprofit use move study. great technologies for of of COPD the management this to Foundation be better It's partner of digital help with will through ATS this from accelerated to
COVID-XX the remote earlier, care movement accelerated apnea in our has fully As to businesses. and ventilation we core discussed sleep
patients locations, solutions pharmaceutical health diseases. digital role leveraging important for Propeller and hospital, growing to adherence these an our technology COPD the in continues world-leading for out at of the outside keeping care play the Propeller's acute platform asthma, Looking
so Propeller of during using importance acute don't is the health to want rising Active use of actually more awareness that people due of the increased to the care crisis. they're technology so. preventative has go and the just to to think COVID-XX medicines fact do settings, this We respiratory and
yet with our health. XXXX system as well we our seeing not Propeller it's updated revenue, XXXX are they work as and care you year health technology health material to significant as We'll throughout overall calendar in and Propeller's pharmaceutical While for increased keep global adopt partners platform the support on any to milestones population ResMed's with asthma beyond. interest COPD, with partners systems
I'd into business broader of and briefly like I Before discussion long-term software-as-a-service critical ResMed's portfolio. how SaaS recap to the believe transition a our to to it out-of-hospital our why is that business, fits success we
Our consistent of of is present hospital. care many COVID-XX that locations outside examples latest are view worldwide. the contamination of of types the delivered evolution just be The of the hospital one in that the will of hospitals contagions is the health care system with
is is health, portfolio a to senior facilities, outside independent to beyond. care system skilled can costs reduced settings, home. to are across and home home hospital. assisted hospital have happier simply than setting health to These patient efficiency living, their of a a and in increased vision versus from the care enable choice, the and ultimate well transfer residence providers living settings Our the better seamlessly outcomes of where the hospital nursing healthier their choice of as residential and People as
business leverages age want supports the trend clearly ResMed's to for against aim. to and place SaaS in the triple The continued execution seniors global
a disease additional growth chronic enable across patient's creating cycle, SaaS participate deeply in options. strategic more us Our life businesses broader to
our business from period grew quarter, a at ago. the the XX% software-as-a-service During year
SaaS optimizing integrating portfolio growth. and to We out-of-hospital support are long-term this
digits. and weighted that run long to that high to SaaS execute this exceed to long-term SaaS of rate as We believe we growth in clearly average beat our markets that the continue the growth that we single strategy. the quarter, the we serve plan We in is
care overflow a in this And in been hit the in out-of-hospital been have will also health our COVID-XX extremely hard home out-of-hospital the COVID-XX, to these hospitals. hospitals. nursing crisis, During many to has impact use nursing switched their flow to due quarters. at from there patient coming settings surgeries facilities support a Skilled by MatrixCare reduction growth elective and volumes facilities have and business reduction
We expect market medium current portfolio and primary be the passes surgeries growth term and we businesses of few patient mid recovery returns. to to serve single-digit people long before their our range the SaaS in its physicians quarters, surge to that high to single-digit next in for their and care COVID-XX the the to volume growth as elective return return in
in up the automation our with COVID-XX industry for the programs, and ballast Resupply end-to-end of In area this during creates for SnapWorx. SnapWorx The SaaS the with growth contact we the acquisition live patient our of quarter, sleep apnea for together, resupply boat HME combination Brightree support engagement SnapWorx beyond. and a HME the called these set in tech services customers. during business SnapWorx that technology better the of largest including for and types the been management Brightree's customers new provides of strong workflow and a And crisis completed third ongoing HME of company call the is and through success optimization lockdowns. the increased of resupply patient has an workflow the base portfolio, customers.
portfolio driver our enabler our critical triple long-term impact a important an of ability success of and aim. In SaaS to summary, our the is
leadership We are long-term investing in and for in this growth space. SaaS
world portfolio of our ResMedians our who dedication across need it help. health entire performance the challenging business I global times. for during people Our the quarter dedications the And all systems resiliency highlights demonstrates would deliver during, and the customers, our providers the of the ResMed the call, of what over clinicians, and the extremely to
impacts headwinds are region from by detailed by of with tailwinds customer, business modeling by city, the crisis, COVID-XX Looking by and impacts we forward, of line. scenarios and
just the business the sleep talked exactly increased crisis our patient fundamentals world. flows masks across we and diagnosis strong, geographies, we also are headwinds our about, temporary these and While is how times how overall related our we will from And in headwinds by city, each them. Asia and will long open as fast coming up. the they know and be seen there face don't ResMed serve but related as up, will seeing unfold up uncertain to specifically they weeks months, open The ventilation I and we know tailwinds country the ventilation but SaaS we will We region days, over these apnea the around devices, are last. know business of demand have to don't continues in Europe, and tailwinds for open and economies
of so most health And thing We're be best patients grow support our to start as be realities to of open can that will they them health out-of-hospital been solutions the digital has that we for now help customers know solutions with open-up be and we needs. one backlog channel's who and sleep scalable those care to there the investing now. the the need ready there a up, help to for and apnea, asthma COPD,
We front. are the from leading
highlighted the I health importance has crisis mentioned earlier. strategies digital COVID-XX the of our nature of The
over for health, health days remote We're can when not made to to them monitoring, challenging digital X, over patient nation, remote every they is incredibly only benefit has by last the is every XXX track, XX-plus dealing now bring investments ability company, years market in on government million it's improve out-of-hospital this health lives that Our need setup, the population what we with welcome have extensive care help to X in every management XX the not in ResMed accelerated been in we that it. we glad XXXX and months. these crisis. just offer think one last This
This our in projected digital significant represents to value the strong digital global of combined our out-of-hospital positioning models and health tailwind happening already health The including health, also and medium growing recognition to We the with pipeline over that term. SaaS digital apnea, in business. leadership of for sleep is long us think medium global health combination for and confidence solidifies virtual products COPD, the role reimbursement support virtual in that a ResMed's technology new of diagnosis with asthma gives combined accelerated our the setup, of changes remote unique a new tech, growth future. long-term monitoring and the med and and will but digital of ResMed strong the solutions, the are acceptance this in
we thousands hand Before to remarks, COVID-XX tens role clinicians over providing while like fight masks are worldwide we crisis, call to for I'd to of Brett support of the ventilation done. that ventilators, have more to the many, many I commit already not clinical his a significant and played
normal around during the connected be only world even deliver crisis, for ever do but health call countries not And health the more quarter patient the this than as that digitally in respiratory medicine they in will more before. coming in and and masks We coming world through new post-COVID-XX care COVID-XX what we the support ventilators, will and surge. digital we to to digitally more there will be ventilation the enabled more more go systems quarters
to Brett? With that, Sydney. I'll in turn Brett over the call
